Evidence map›Paper›PMID 29059183›Full record

ArticlePLoS computational biology2017

Machine learning to design integral membrane channelrhodopsins for efficient eukaryotic expression and plasma membrane localization.

Claire N Bedbrook, Kevin K Yang, Austin J Rice, Viviana Gradinaru, Frances H Arnold

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 132 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Biophysics-based protein language models for protein engineering.bioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. Addressing epistasis in the design of protein function.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Fast, accurate ranking of engineered proteins by target-binding propensity using structure modeling.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  14. One-shot design elevates functional expression levels of a voltage-gated potassium channel.Protein science : a publication of the Protein Society · 2024
    Article
  15. Review
  16. Review
  17. Is Novelty Predictable?Cold Spring Harbor perspectives in biology · 2024
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Claire N BedbrookDivision of Biology and Biological Engineering; California Institute of Technology; Pasadena, California; United States of America.
Kevin K YangDivision of Chemistry and Chemical Engineering; California Institute of Technology; Pasadena, California; United States of America.
Austin J RiceDivision of Chemistry and Chemical Engineering; California Institute of Technology; Pasadena, California; United States of America.
Viviana GradinaruDivision of Biology and Biological Engineering; California Institute of Technology; Pasadena, California; United States of America.
Frances H ArnoldDivision of Biology and Biological Engineering; California Institute of Technology; Pasadena, California; United States of America.
California Institute of Technology · USPasadena City College · USDivision of Chemistry · US

Funding

Engineering Microbial Opsins for Neuroscience via Structure-Guided RecombinationR21MH103824 · NIMH · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ARNOLD, FRANCES H, GRADINARU, VIVIANA · 2014 to 2015
$458k
Structural characterization and structure-based engineering of channelrhodopsins for neurobiologyF32GM116319 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI RICE, AUSTIN J. · 2015 to 2017
$119k
Opsineering: Engineering Novel ChannelRhodospins for Optogenetics ApplicationsF31MH102913 · NIMH · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI BEDBROOK, CLAIRE NICOLE · 2014 to 2016
$110k
NIGMS NIH HHS F32 GM116319NIMH NIH HHS F31 MH102913NIMH NIH HHS R21 MH103824
6 · The paper itself

Abstract

There is growing interest in studying and engineering integral membrane proteins (MPs) that play key roles in sensing and regulating cellular response to diverse external signals. A MP must be expressed, correctly inserted and folded in a lipid bilayer, and trafficked to the proper cellular location in order to function. The sequence and structural determinants of these processes are complex and highly constrained. Here we describe a predictive, machine-learning approach that captures this complexity to facilitate successful MP engineering and design. Machine learning on carefully-chosen training sequences made by structure-guided SCHEMA recombination has enabled us to accurately predict the rare sequences in a diverse library of channelrhodopsins (ChRs) that express and localize to the plasma membrane of mammalian cells. These light-gated channel proteins of microbial origin are of interest for neuroscience applications, where expression and localization to the plasma membrane is a prerequisite for function. We trained Gaussian process (GP) classification and regression models with expression and localization data from 218 ChR chimeras chosen from a 118,098-variant library designed by SCHEMA recombination of three parent ChRs. We use these GP models to identify ChRs that express and localize well and show that our models can elucidate sequence and structure elements important for these processes. We also used the predictive models to convert a naturally occurring ChR incapable of mammalian localization into one that localizes well.

Indexed as

Drug DesignMachine LearningCell MembraneHEK293 CellsHumansIon ChannelsLipid BilayersRhodopsinSequence Analysis, ProteinStructure-Activity RelationshipSubcellular FractionsIon ChannelsLipid BilayersRhodopsin

Identifiers

PMID29059183
PMCPMC5695628
OpenAlexW2765744127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.